We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 832

Will the Court of Justice of the European Union invalidate "safe harbor" agreements because of the Prism scandal?
  • Baker & McKenzie
  • European Union
  • November 7 2014

After Directive 200624EC on Data Retention, which the ECJ ruled to be invalid on April 8, 2014, will the Court invalidate "Safe Harbor" agreements


Processing of "health data" by lifestyle and wellbeing apps: clarification by the Article 29 Working Party
  • Baker & McKenzie
  • European Union
  • April 6 2015

Following a request by the European Commission, the Article 29 Working Party has published a letter with the purpose of clarifying the scope of the


First medicine approved under early access scheme
  • Baker & McKenzie
  • European Union
  • April 6 2015

Pembrolizumab, a treatment for advanced melanoma marketed by Merck Sharp & Dohme, has become the first drug to be approved by the MHRA under the


Cap on bankers' bonuses - EBA takes aim at role-based allowances
  • Baker & McKenzie
  • European Union, United Kingdom
  • November 30 2014

New rules on pay for certain staff in the financial services sector limit the amount of variable pay affected staff may receive to 100 percent of


Disclosure obligations under the EFPIA Disclosure Code entered into force on 1 January 2015
  • Baker & McKenzie
  • European Union
  • February 6 2015

The EFPIA Code on Disclosure of Transfers of Value from pharmaceutical companies to healthcare professionals and healthcare organizations (EFPIA


Product & operational risk PG: 2014 annual review
  • Baker & McKenzie
  • European Union
  • February 3 2015

2014 has seen a raft of changes to EU product safety legislation and more are on the horizon. In this article we provide an update on the following:


Does the inability to disregard costs and expenses on dividends from non-French EU subsidiaries constitute a restriction to freedom of establishment?
  • Baker & McKenzie
  • European Union, France
  • February 3 2015

French Court refers important question to the CJEU. Its decision could have significant consequences for groups. With its eligible French


Tax treatment of foreign-sourced dividends: the law is changed but Spain is still referred to the European Court of Justice
  • Baker & McKenzie
  • European Union
  • February 3 2015

The European Commission has referred Spain to the CJEU, following a request made in June 2013 to amend its tax rules on investment in non-resident


Belgian Fairness Tax violates EU law, according to European Commission
  • Baker & McKenzie
  • Belgium, European Union
  • February 3 2015

The European Commission is apparently of the opinion that the Belgian Fairness Tax is incompatible with EU law, and more specifically with the EU


Dutch fiscal unity regime expanded: new opportunities
  • Baker & McKenzie
  • European Union, Netherlands
  • February 3 2015

Following a CJEU ruling that the Dutch fiscal unity regime breached European law, Dutch law will be amended so that a fiscal unity can be created by